| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,990,000 | 1,966,000 | 2,215,000 | 2,202,000 | | Cost of Revenue | 1,531,000 | 1,641,000 | 1,898,000 | 1,844,000 | | | Gross Profit | 459,000 | 325,000 | 317,000 | 358,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 335,000 | 344,000 | 310,000 | 283,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 124,000 | (19,000) | 7,000 | 75,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,000) | (78,000) | 8,000 | (15,000) | | Earnings Before Interest And Taxes | 104,000 | (85,000) | 36,000 | 93,000 | | Interest Expense | 47,000 | 35,000 | 9,000 |
-
| | Income Before Tax | 57,000 | (120,000) | 27,000 | 93,000 | | Income Tax Expense | 9,000 | (1,000) | 28,000 | 27,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 48,000 | (119,000) | (1,000) | 66,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (9,000) | 6,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 48,000 | (119,000) | (10,000) | 72,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $48,000 | ($119,000) | ($10,000) | $72,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
